A First-of-its-Kind Female Arousal Cream

Are there pills or other medications that increase sex drive in women?
Read next
Does Viagra work for women?
Where the Magic Happens

Moreover, 4 (12.5%) of 32 women in the B sequence did not complete the study for adverse events, all during sildenafil usage. They stopped taking the drug for [1] headache, vision problems, and nausea (n = 1), [2] vision problem and headache (n = 1), and [3] headache and nausea (n = 2). Therefore, the incidences of the most commonly recorded adverse events reported by subjects during the use of sildenafil were headache (12.5%), nausea (6.2%), and vision problem (6.2%).

Side Effect	Severity	Frequency	Management Tips
Headache	Mild to moderate	Frequent	Hydration, pain relievers
Flushing	Mild	Common	Cooling measures
Nasal Congestion	Mild	Occasional	Decongestants
Dizziness	Mild	Less common	Sitting or lying down
Visual Disturbances	Rare	Rare	Seek medical attention

Each adverse event was predominantly transient and mild in nature.

Country	Legal Status	Prescription Required	Notes
USA	Approved for certain uses	Yes	Off-label for women often not approved
UK	Prescription-only	Yes	Approved for male ED; off-label use in women
Canada	Restricted use	Yes	Prescription required; variable by province
Australia	Prescription-only	Yes	Limited clinical guidelines for women

During the study, each women had well-controlled diabetes. The mean HbA1c value obtained during each treatment was similar to that observed at baseline (P=NS).

Are there pills or other medications that increase sex drive in women?

The American Foundation for Urologic Disease definition of Female Sexual Function Disorders (26) was used to define SAD, that is, the persistent or recurring inability to attain or maintain sufficient sexual excitement, causing personal distress, which may be expressed as a lack of subjective excitement or genital (lubrication/swelling) or other somatic responses. The women with acquired sexual dysfunction and SAD were the focus of our study. Finally, one of our hypotheses was that if arousal were enhanced, orgasm could possibly be facilitated. To measure sexuality we used the Personal Experiences Questionnaire (PEQ) (27), a self-reporting questionnaire based on the McCoy Female Sexuality Questionnaire (28). Using the PEQ, it was possible to assess the efficacy of each treatment with respect to baseline values.

Knowledge Gaps in Urologic Care of Female Spinal Cord Injury Patients

Qualitative items were answered on a 5-point Likert scale, ranging from 1, not at all, to 5, a great deal. Quantitative items were answered as 0, never; 1, less than once a week; 2, once or twice a week; 3, several times a week; 4, once a day/sometimes twice; and 5, several times a day. The PEQ was completed by each woman and handed back to the fieldworker. Finally, each woman underwent color Doppler ultrasound to measure clitoral blood flow. Ultrasound was performed using a SonoAce 8800 (Medison Co., Seoul, Korea) with a 7.5-MHz linear transducer by the same investigator.

Addyi (Flibanserin)

Each woman was scanned in the gynecological position. The Doppler translabial probe was placed sagittally on the clitoris at an angle of <20 degrees, without exerting any significant pressure on the tissues. After identifying the clitoral artery using color flow mapping, the Doppler probe was positioned over the vessel and at least three sequential Doppler waveforms were obtained. The peak systolic velocity (PSV), the end diastolic velocity (EDV), the resistance index (RI = PSV − EDV/PSV), and the pulsatility index (PI = PSV − EDV/mean flow velocity of clitoral artery) were calculated. A double-blind, crossover, placebo-controlled study design was performed. The BMI did not show any significant variation with respect to baseline values (P=NS). The sexual interview showed that the mean duration of sexual dysfunction was 3.5 years (range, 2.2–4.5 years).

Product	Dosage	Quantity + Bonus	Price
Viagra Generic	150mg	360 + 10 Pills	423.48€ 403.31€
Viagra Generic	150mg	90 + 6 Pills	147.18€ 140.17€
Kamagra Soft Tabs	100mg	60 + 4 Pills	180.59€ 171.99€
Viagra Generic	25mg	360 + 10 Pills	213.68€ 203.50€
Viagra Generic	100mg	360 + 10 Pills	330.21€ 314.49€
Viagra Generic	100mg	180 + 8 Pills	199.37€ 189.88€
Viagra Generic	100mg	30 + 4 Pills	60.91€ 58.01€
Viagra Generic	50mg	180 + 8 Pills	158.82€ 151.26€
Viagra Generic	50mg	30 + 4 Pills	54.26€ 51.68€
Viagra Generic	150mg	30 + 2 Pills	72.32€ 68.88€
Viagra Generic	200mg	270 + 10 Pills	379.76€ 361.68€
Kamagra Soft Tabs	100mg	120 + 6 Pills	311.78€ 296.93€
Viagra Generic	25mg	20 Pills	37.74€ 35.94€
Viagra Generic	100mg	120 + 6 Pills	149.50€ 142.38€

Subjects mainly reported arousal and orgasm difficulties and dyspareunia. Moreover, they reported a decrease in sexual satisfaction and in sexual activity.

Does Viagra work for women?

The efficacy of treatment was the primary end point based on the proportion of successful attempts, defined as sexual arousal levels, occurring after dosing. Safety was considered a further end point of this study, data being collected throughout the study period, and included recording adverse events, vital signs, and changes in laboratory test values for standard hematology and biochemistry variables. Patients provided information recorded on diary cards and were reviewed at each study visit concerning sexual activity. After defining inclusion criteria at the screening, according to a computer-generated list of random number groups, each woman was randomly allocated to one of the two possible sequences, each of which constituted two medication series: sildenafil 100 mg/placebo (A sequence) and placebo/sildenafil 100 mg (B sequence). Women were assessed before being treated and during each treatment by one investigator.

Sexual Function after Spinal Cord Injury: Innervation, Assessment, and Treatment

Both the woman and the attending doctor carrying out the procedure were blinded to the two drugs. The investigator was not involved in the recruitment of the women and did not know the computer-generated randomization list and the assignment of the treatment group according to the sequence of recruitment. The codes were broken after the study was completed. The crossover study design was used to define whether the treatment with sildenafil was effective with respect to placebo. Each woman took sildenafil or placebo 1 hour before each sexual intercourse.

Bremelanotide (Vyleesi)

The usage of 200mg sildenafil citrate the drug was not more than once daily. Each woman received each treatment for 8-week periods. There was a 7-day washout period between treatments. We chose a 1-week washout period on the basis of our previous studies using a similar intervention by which we did not observe any carryover effect (22, 34). The PEQ was used at baseline, at the washout, and after treatments. Excluding the frequency of intercourse (P<.05), each aspect of sexuality during placebo intake was similar to that observed at baseline (P=NS). During sildenafil intake, dyspareunia decreased with respect to baseline and placebo (P<.05).

Female patients should be cautious with sildenafil due to lack of approval.
Erectile dysfunction medications can interact with other drugs, affecting women as well.
Some studies suggest sildenafil may help women with arousal issues but are inconclusive.
Sildenafil may improve clitoral blood flow, enhancing sensitivity.
Libido enhancement from sildenafil varies based on individual health factors.
Self-medicating women with sildenafil without supervision can be risky.

Finally, desire and frequency of fantasies did not change during both treatments with respect to baseline (P=NS). All women enrolled in the study underwent baseline color Doppler ultrasound; at the end of the A sequence, 32 women (response rate, 88.9%) underwent color Doppler ultrasound, while at the end of the B sequence 28 women (response rate, 77.7%) underwent color Doppler ultrasound. Table 2 shows the results of the color Doppler ultrasound measurements and statistical analysis.

Sildenafil works by relaxing blood vessels, increasing blood flow to genital areas.
Female sexual arousal disorder may potentially be treated with sildenafil.
Research shows mixed results regarding sildenafil's effectiveness in women.
Sildenafil is not approved by the FDA specifically for women’s sexual problems.
Possible risks for women include headaches and low blood pressure.
Always consult a healthcare provider before trying sildenafil for women.

In both the A and B sequences of drug administration, sildenafil improved clitoral blood flow with respect to placebo (P<.05). During sildenafil administration, the mean PSV (16.78 ± 1.65) markedly increased and the mean EDV (−5.1 ± 1.2) significantly decreased from baseline. On the contrary, placebo was not able to produce any change with respect to baseline (P=NS). Moreover, the mean RI (0.71 ± 0.32) was significantly lower and the mean PI (1.81 ± 0.77) was significantly higher compared with both baseline and placebo values (P<.05). Our study was the first to take into consideration type 1 diabetic women treated with sildenafil.

Some women seek sildenafil for increasing genital blood flow and sensation.
The placebo effect can influence perceived benefits in women using sildenafil.
Women with cardiovascular risk should avoid sildenafil unless approved by a doctor.
Topical or alternative therapies might be considered alongside or instead of sildenafil.
Scientific consensus on sildenafil’s safety for women remains under development.
Proper dosing and medical oversight are key to minimizing risks.

In our pilot study, the treatment with 100 mg sildenafil was effective in modifying both sexuality and clitoral blood flow in premenopausal women with type 1 diabetes.

Where the Magic Happens

Arterial clitoral color Doppler ultrasound was performed at baseline and during the usage of drugs. All adverse events reported by the woman were recorded, irrespective of any random relationship with the study drug. Intention-to-treat analyses were performed for all efficacy variables and included all patients who had a baseline evaluation and had at least one efficacy assessment after the baseline visit. We included in the analysis the subjects that had missing information on one or more questionnaire items. The last observation carried forward was used to select data such that missing data were replaced by values from the last available assessment during treatment before the respective assessment.

Key takeaways

Furthermore, women who stopped treatment for adverse events were included in the analysis. For comparisons among baseline, sildenafil 100 mg, and placebo sexual PEQ scores, the nonparametric Wilcoxon’s rank-sum test was used. Separate analyses were performed for the arousal score (primary end point) and desire, orgasm, enjoyment of sexual activities, satisfaction with frequency, and frequency of intercourse. Paired Student’s t-test was performed to compare changes between baseline sildenafil and placebo values of clitoral arterial blood flow. Considering the order in which the treatments were allocated, data was analyzed by Student’s t-test, using the Bonferroni method of correction for multiple comparisons if a significant F ratio was found. Techniques measuring hemodynamic changes in the vagina and clitoris using clitoral tissue concentrations of hemoglobin, vaginal luminar pressure, and clitoral intracavernosal pressure could involve noninvasive instruments (8). However, we should use more direct diagnostic procedures to evaluate hemodynamic events of vaginal and clitoral pathways. The color Doppler ultrasound has become a first-level diagnostic procedure to measure the penile blood flow of men with ED (30) and might be a useful method to study the female sexual response by measuring clitoral blood flow (31).

Medication Type	Interaction Effect	Risk Level	Notes
Nitrates	Severe hypotension	High	Contraindicated
Alpha-Blockers	Increased risk of hypotension	Moderate	Dose adjustment may be needed
CYP3A4 Inhibitors	Increased sildenafil levels	Moderate to high	Watch for adverse effects
CYP3A4 Inducers	Decreased effectiveness	Moderate	Alternative treatments considered

By color Doppler ultrasound, we observed a decreased mean RI and an increased mean PSV and PI of the clitoral artery.